– Intelerad and Zebra Medical Vision join forces to accelerate AI adoption through newly released Intelerad’s Odyssey workflow solution.
– The partnership will further help radiologists increase productivity, improve clinical decisions and provide high-quality care globally.
After expanding its “all-in-one” AI bundle, which includes 3 FDA 510(k) clearances, the deep learning medical imaging analytics company, Zebra Medical Vision, is now announcing a new joint partnership with Intelerad Medical Systems™, a leader in enterprise workflow solutions. The joint program will leverage Intelerad’s newly released Odyssey designed to encourage the adoption of artificial intelligence without the prohibitive costs usually associated with such programs.
Partnership Details
The positive impact of artificial intelligence technology has been demonstrated in many fields, including that of radiology. Indeed, AI can help radiologists increase productivity, improve clinical decisions and, ultimately, provide high-quality care when the technology is tightly managed and smartly integrated in the workflow.
Odyssey harnesses the power of artificial intelligence and the technology behind the Intelerad worklist to offer an unparalleled workflow management solution, comprised of the clinical AI engine, powered by Zebra-med’s AI1 ™ “all-in-one” bundle of FDA cleared AI applications. Connected via API, it analyses the images and automatically returns the findings to the worklist which then escalates the study to the radiologist’s attention.
Thanks to this collaboration, Zebra-Med’s AI1 bundle will be supporting Intelerad’s Odyssey, the new AI-augmented workflow solution, designed to encourage the adoption of artificial intelligence without the typical costs. This solution harnesses the power of AI to offer an unparalleled workflow management solution, which will be powered by Zebra-Med’s AI technology.
Removing Critical Barriers to AI Accessibility
With Odyssey, Intelerad and Zebra-Med are removing two critical barriers to AI accessibility: the prohibitive cost of AI platforms and the need for demonstrated impact prior to committing resources to AI. Through a pay-per-study model and by eliminating the high, upfront flat-fee models typically offered in the market, Intelerad intends to encourage AI adoption by healthcare service providers of all sizes. For a limited time, Intelerad has pre-paid as well as secured a 12 month trial for its customers to utilize Zebra-Med’s clinical algorithms, at a 100% discount.
“Odyssey will deliver state-of-the-art clinical AI solutions directly integrated into the radiologists’ natural workflow and tailored to the needs of individual organizations,” said Chris Wood, Chief Technology Officer at Intelerad. “With Zebra-Med’s AI1, we are committed to providing a broad and growing portfolio of high-value, innovative technology solutions to our customers and this unprecedented approach to artificial intelligence in radiology will extend our leadership position in workflow management.”
